Regulatory status of software (including apps) used in the diagnosis, treatment and management of patients with coronavirus (COVID-19)

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Coronavirus, Health And Social Care

Published

June 5, 2020

Last updated

December 17, 2021

Description

Advice for manufacturers, members of the public and professional users of software or apps being used during the COVID-19 pandemic.

Organization

Country / Region

United Kingdom

License

Open Government Licence 2.0 (United Kingdom)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed